U C B
U C B and the 11 companies it consolidates according to the LEI register: the structure, the figures, each company's health and where the risk sits.
Sum of the filed annual accounts of 7 of the 7 Belgian companies (fiscal years 2025). Not a consolidation: receivables, participations and sales between group companies are not eliminated, so they count.
U C B also files consolidated accounts (fiscal year 2025): the real group figures, with intra-group positions eliminated. Checked does not read their figures yet; the document is at the National Bank's Central Balance Sheet Office.
Group risk
How healthy the group's Belgian companies are, and where the risk sits. A weak subsidiary can cost the parent money, and the other way round.
- The parent itself: U C B, no verdict.
- 51.0% of the added-up total assets sits in one company: UCB PHARMA.
- None of the added-up total assets sits at a company with an elevated or high risk.
- No bankruptcy, liquidation, negative equity or overdue accounts among the Belgian companies.
Group structure
Who consolidates whom, according to the LEI register. Consolidating means control: the parent takes the subsidiary into its group accounts.
- U C B10 subsidiariesNo verdict€12.51bn €9.16bn 2025
- No verdict€4.1m €4.1m 2025
- Fair · 55€7.15bn €1.18bn 2025
- Healthy · 77€38.6m €38.6m 2025
- UCB PHARMA1 subsidiaryHealthy · 75€20.74bn €16.23bn 2025
- UCB PHARMA GMBH
- No verdict€214.5m €213.8m 2025
- Healthy · 68€28.8m €28.7m 2025
- UCB FINANCE N.V.
- UCB MANUFACTURING IRELAND LIMITED
- UCB PHARMA LIMITED
- ZOGENIX INTERNATIONAL LIMITED
High risk Elevated Healthy Fair No verdict Amounts: total assets and equity from the latest accounts.
Shared directors
Who sits on the boards of several group companies. This is where control over the group sits in practice.
- 2
Events in the group
Bankruptcies, director changes, capital changes and other publications of all Belgian group companies, over the last two years.
-
2 reappointed
-
1 director appointed, 1 director resigning
-
1 director appointed, 1 director resigning, 2 reappointed
-
1 director appointed, 2 directors resigning, 2 reappointed
-
Authorised capital
-
Authorised capital
-
Capital decrease of €75,682,191.03
What is my exposure to this group?
The companies of this group you keep in your lists or follow, seen together.
Sign in to see which customers or suppliers from your lists belong to this group, and how they stand.
Where do these figures come from?
The group's make-up comes from the LEI register (GLEIF): which company consolidates which other, directly or ultimately. A company whose link the register does not state is not listed here, even if it does belong to the group.
The amounts are those of the annual accounts each Belgian company filed with the National Bank, added up without consolidation. The verdict per company is that of its dossier on Checked.be. Everything is updated every night.
Updated on 01-10-2026